Presentation TCT 2025 TCT 1269: Associations Between AI Based-Quantitative Coronary Plaque Analysis, Calcium Score, and ASCVD Score with Major Adverse Cardiovascular Events: An Observational Study from Piedmont Heart Institute CCTA Registry Presenter: Venkateshwar Polsani October 28, 2025
Presentation TCT 2025 TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies Presenter: Claudio Laudani October 28, 2025
Presentation TCT 2025 TCT 1189: The Impact of Concomitant Mitral Regurgitation on Cardiovascular Events and Mortality After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Presenter: Mohammad Reza Movahed October 28, 2025
Presentation TCT 2025 TCT 98: Elevated Calcium-Phosphate Product (CPP) is Independently Associated With Higher Cardiovascular Procedure Rates and Adverse Outcomes in Chronic Kidney Disease (CKD): A Propensity Score–Matched Analysis Presenter: Muhammad Raffey Shabbir October 27, 2025
Presentation TCT 2025 TCT 296: 25-Year Trends in Postoperative Mortality in U.S. Adults with Ischemic Heart Disease Presenter: Zeyad Kholeif October 27, 2025
Presentation TCT 2025 TCT 476: Synergistic Impact of Insulin Resistance and Hepatic Fibrosis on Cardiovascular Events in Patients with Coronary Artery Disease: A Machine Learning Subtyping and Interaction Analysis Presenter: Zhihao Zheng October 27, 2025
Presentation TCT 2025 TCT 894: Development and Internal Validation of an AI-Driven Model for 5-Year Cardiovascular Disease Risk Prediction in the Canadian Longitudinal Study on Aging : Comparative Performance vs. Traditional Risk Scores Presenter: Robert Avram October 27, 2025
Presentation TCT 2025 TCT 554: Understanding the burden of multivalvular disease in patients with cardiomyopathy referred to cardiovascular magnetic resonance Presenter: Davide Margonato October 26, 2025
Presentation TCT 2025 TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database Presenter: Aymen Ahmed October 26, 2025
Presentation TCT 2025 TCT 775: Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database Presenter: Aymen Ahmed October 26, 2025
Presentation TCT 2025 Pacing and Functional Valve Disease: Mechanisms & Management of MR, TR, and Heart Failure Presenter: Josip Katinic October 25, 2025
Presentation TCT 2025 The Vein Advantage: Venous Arterialization for CLI Presenter: Laura Petrikovic October 25, 2025
Presentation TCT 2025 Dissolving Barriers: Bioresorbable Scaffolds in Action Presenter: Catherine Popik October 25, 2025
Presentation TCT 2025 Under Pressure: Treating Hypertension with Renal Denervation Presenter: David P. Lee October 25, 2025
Presentation TCT 2025 Let’s Get Comfortable: Cath Lab Ergonomics and Radiation Safety Presenter: David G. Rizik October 25, 2025
Presentation ACC 2025 Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial Presenter: Darren K. McGuire March 29, 2025
Presentation THT 2025 Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation Presenter: Carolyn Lam February 11, 2025
Presentation THT 2025 Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD Presenter: Josephine Harrington February 11, 2025
Presentation THT 2025 Inflammation and Heart Failure: Pathophysiology and Clinical Implications Presenter: Marat Fudim February 11, 2025
Presentation THT 2025 Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure Presenter: Mark Petrie February 11, 2025